KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Resmed (RMD) Non-cash Items (2016 - 2021)

Historic Non-cash Items for Resmed (RMD) over the last 10 years, with Q2 2021 value amounting to $158.5 million.

  • Resmed's Non-cash Items rose 4409.09% to $158.5 million in Q2 2021 from the same period last year, while for Jun 2021 it was $158.5 million, marking a year-over-year increase of 4409.09%. This contributed to the annual value of $158.5 million for FY2021, which is 4409.09% up from last year.
  • As of Q2 2021, Resmed's Non-cash Items stood at $158.5 million, which was up 4409.09% from $110.0 million recorded in Q2 2020.
  • Resmed's Non-cash Items' 5-year high stood at $222.3 million during Q2 2018, with a 5-year trough of $110.0 million in Q2 2020.
  • For the 4-year period, Resmed's Non-cash Items averaged around $173.7 million, with its median value being $183.1 million (2017).
  • As far as peak fluctuations go, Resmed's Non-cash Items skyrocketed by 1429.31% in 2018, and later soared by 4409.09% in 2021.
  • Over the past 4 years, Resmed's Non-cash Items (Quarter) stood at $194.5 million in 2017, then increased by 14.29% to $222.3 million in 2018, then crashed by 50.52% to $110.0 million in 2020, then skyrocketed by 44.09% to $158.5 million in 2021.
  • Its Non-cash Items was $158.5 million in Q2 2021, compared to $110.0 million in Q2 2020 and $222.3 million in Q2 2018.